The global dialysis concentrate market was valued at $2,692.6 million in 2020 and is projected to reach $4,531.5 million by 2030, registering a CAGR of 5.40% from 2021 to 2030.
Dialysis concentrates or dialysis fluid mainly consists of three components. It includes purified water, glucose, and electrolytes. The concentration of electrolytes nearly resembles that occurs naturally in the blood. Dialysis concentrate is prepared according to the individual's requirement that helps to regulate electrolyte and acid-base balance, in turn, removing metabolic waste products from the body. There are primarily two types of concentrates for hemodialysis, bicarbonate (base) and acid. Acid and bicarbonate are mixed with treated water, which then forms the dialysis fluid (dialysate). Hemodialysate is the solute and fluid that flows through the dialyzer during the process of hemodialysis. Once the acid concentrates, water and bicarbonate concentrate are combined. The final dialysate can contain up to 3 buffer components. These components depend on the amount of acid concentrate used.
The main driving factors that drive growth of the dialysis concentrate market include, surge in incidences of kidney related diseases and problems associated with kidney transplants as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, the rise in prevalence of lifestyle and chronic diseases, such as obesity, diabetes, and hypertension, is projected to further supplement the global dialysis concentrate market growth. Conversely, the rise in complications related to dialysis treatment, such as infections, hypotension, fluid overload, and access point bleeding, is expected to obstruct growth of the market in the coming years. Similarly, reimbursement policy concerns in emerging nations impedes the growth of the market, as reimbursement for dialysis varies widely in terms of amount & duration between these countries and does not necessarily cover real treatment costs, further discouraging patients and physicians for considering the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach is expected to offer profitable opportunities for the growth of the market during the forecast period.
The global dialysis concentrate market is segmented on the basis of type, application, dialysis site, and region to provide a detailed assessment of the market. By type, it is divided into acid concentrates, bicarbonate concentrates, and peritoneal dialysis fluid. By application, it is classified into hemodialysis and peritoneal dialysis. Based on dialysis site, it is categorized into hospital, clinics & dialysis centers, and home dialysis. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Dialysis concentrates or dialysis fluid mainly consists of three components. It includes purified water, glucose, and electrolytes. The concentration of electrolytes nearly resembles that occurs naturally in the blood. Dialysis concentrate is prepared according to the individual's requirement that helps to regulate electrolyte and acid-base balance, in turn, removing metabolic waste products from the body. There are primarily two types of concentrates for hemodialysis, bicarbonate (base) and acid. Acid and bicarbonate are mixed with treated water, which then forms the dialysis fluid (dialysate). Hemodialysate is the solute and fluid that flows through the dialyzer during the process of hemodialysis. Once the acid concentrates, water and bicarbonate concentrate are combined. The final dialysate can contain up to 3 buffer components. These components depend on the amount of acid concentrate used.
The main driving factors that drive growth of the dialysis concentrate market include, surge in incidences of kidney related diseases and problems associated with kidney transplants as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, the rise in prevalence of lifestyle and chronic diseases, such as obesity, diabetes, and hypertension, is projected to further supplement the global dialysis concentrate market growth. Conversely, the rise in complications related to dialysis treatment, such as infections, hypotension, fluid overload, and access point bleeding, is expected to obstruct growth of the market in the coming years. Similarly, reimbursement policy concerns in emerging nations impedes the growth of the market, as reimbursement for dialysis varies widely in terms of amount & duration between these countries and does not necessarily cover real treatment costs, further discouraging patients and physicians for considering the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach is expected to offer profitable opportunities for the growth of the market during the forecast period.
The global dialysis concentrate market is segmented on the basis of type, application, dialysis site, and region to provide a detailed assessment of the market. By type, it is divided into acid concentrates, bicarbonate concentrates, and peritoneal dialysis fluid. By application, it is classified into hemodialysis and peritoneal dialysis. Based on dialysis site, it is categorized into hospital, clinics & dialysis centers, and home dialysis. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the dialysis concentrate market along with the current trends and future estimations to explain the imminent investment pockets.
- A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
- Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
- Extensive analysis of the key segments of the industry helps to understand the application and products of dialysis concentrate used across the globe.
- Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Type
- Acid Concentrates
- Bicarbonate Concentrates
- Peritoneal Dialysis Fluid
By Application
- Hemodialysis
- Peritoneal Dialysis
By Dialysis Site
- Hospital
- Clinics & Dialysis Centers
- Home Dialysis
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
- Asahi Kasei Medical Co. Ltd
- B. Braun Melsungen AG
- Baxter
- Dialysis Medical Solutions
- Farmasol
- Fresenius Medical Care
- Hemoclean
- Medites Pharma, spol. s.r.o.
- Nikkiso
- Nipro Renal Solutions
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: DIALYSIS CONCENTRATE MARKET, BY TYPE
CHAPTER 5: DIALYSIS CONCENTRATE MARKET, BY APPLICATION
CHAPTER 6: DIALYSIS CONCENTRATE MARKET, DIALYSIS SITE
CHAPTER 7: DIALYSIS CONCENTRATE MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
List of Tables
List of Figures
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 232 |
| Published | September 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 2692.6 million |
| Forecasted Market Value ( USD | $ 4531.5 million |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
